advanced or metastatic solid tumor
Showing 1 - 8 of 8
Advanced or Metastatic Solid Tumor, KRAS G12C Mutation Trial in Changsha (BEBT-607Tablets)
Recruiting
- Advanced or Metastatic Solid Tumor
- KRAS G12C Mutation
-
Changsha, Hunan, ChinaXiangya Hospital of Central South University
Nov 2, 2023
Advanced or Metastatic Solid Tumor, Liver Failure Trial in United States (Sacituzumab Govitecan-hziy)
Recruiting
- Advanced or Metastatic Solid Tumor
- Liver Failure
- Sacituzumab Govitecan-hziy
-
Long Beach, California
- +5 more
Jan 6, 2023
Advanced or Metastatic Solid Tumor, Advanced or Metastatic Gastric or Gastroesophageal Cancer, Myeloid or Lymphoid Tumors (MLN)
Active, not recruiting
- Advanced or Metastatic Solid Tumor
- +2 more
-
Gilbert, Arizona
- +60 more
Oct 20, 2022
Advanced or Metastatic Solid Tumor, Pancreatic Ductal Adenocarcinoma, Colorectal Cancer Trial in Tokyo (AB122, TAS-116, TAS-120)
Recruiting
- Advanced or Metastatic Solid Tumor
- +3 more
- AB122
- +3 more
-
Tokyo, JapanA site selected by Taiho Pharmaceutical Co., Ltd.
Aug 5, 2022
Advanced or Metastatic Solid Tumor Trial in Worldwide (Rogaratinib (BAY1163877), Copanlisib (BAY80-6946))
Completed
- Advanced or Metastatic Solid Tumor
- Rogaratinib (BAY1163877)
- Copanlisib (BAY80-6946)
-
Los Angeles, California
- +19 more
Jul 13, 2022
Advanced or Metastatic Solid Tumor Trial in Beijing (Recombinant Humanized Monoclonal Antibody MIL97 for Injection)
Recruiting
- Advanced or Metastatic Solid Tumor
- Recombinant Humanized Monoclonal Antibody MIL97 for Injection
-
Beijing, Beijing, ChinaChinese PLA General Hospital
May 26, 2022
Advanced or Metastatic Solid Tumor, Relapsed Hematologic Malignancy Trial in France (IPPACTTO)
Recruiting
- Advanced or Metastatic Solid Tumor
- Relapsed Hematologic Malignancy
- IPPACTTO
-
Angers, France
- +6 more
Apr 21, 2022